{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T09:45:12Z","timestamp":1743155112963,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493927142"},{"type":"electronic","value":"9781493927159"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-1-4939-2715-9_6","type":"book-chapter","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T11:05:54Z","timestamp":1435057554000},"page":"63-82","source":"Crossref","is-referenced-by-count":0,"title":["Universal BRAF State Detection by the Pyrosequencing\u00ae-Based U-BRAFV600 Assay"],"prefix":"10.1007","author":[{"given":"Alexander","family":"Skorokhod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199\u20136206","journal-title":"J Clin Oncol"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","volume":"164","author":"JH Lee","year":"2011","unstructured":"Lee JH, Choi JW, Kim YS (2011) Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol 164:776\u2013784","journal-title":"Br J Dermatol"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355:51\u201365","journal-title":"N Engl J Med"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1158\/1078-0432.CCR-10-2276","volume":"17","author":"JA Ellerhorst","year":"2011","unstructured":"Ellerhorst JA, Greene VR, Ekmekcioglu CL et al (2011) Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin Cancer Res 17:229\u2013235","journal-title":"Clin Cancer Res"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","volume":"6","author":"MJ Garnett","year":"2004","unstructured":"Garnett MJ, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6:313\u2013319","journal-title":"Cancer Cell"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"e47054","DOI":"10.1371\/journal.pone.0047054","volume":"7","author":"G Safaee Ardekani","year":"2012","unstructured":"Safaee Ardekani G, Jafarnejad SM, Tan L et al (2012) The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis. PLoS One 7:e47054","journal-title":"PLoS One"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman PB, Hausschild A, Robert C et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507\u20132516","journal-title":"N Engl J Med"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/PDM.0b013e31815d059d","volume":"17","author":"SK Kim","year":"2008","unstructured":"Kim SK, Kim DL, Han HS et al (2008) Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 17:118\u2013125","journal-title":"Diagn Mol Pathol"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nmeth.1640","volume":"8","author":"KA Heyries","year":"2011","unstructured":"Heyries KA, Tropini C, Vaninsberghe M et al (2011) Megapixel digital PCR. Nat Methods 8:649\u2013651","journal-title":"Nat Methods"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/j.1365-2265.2006.02646.x","volume":"65","author":"KW Chung","year":"2006","unstructured":"Chung KW, Yang SK, Lee GK et al (2006) Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) 65:660\u2013666","journal-title":"Clin Endocrinol (Oxf)"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2353\/jmoldx.2007.060191","volume":"9","author":"C Spittle","year":"2007","unstructured":"Spittle C, Ward MR, Nathanson KL et al (2007) Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. J Mol Diagn 9:464\u2013471","journal-title":"J Mol Diagn"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"e59221","DOI":"10.1371\/journal.pone.0059221","volume":"8","author":"A Skorokhod","year":"2013","unstructured":"Skorokhod A, Helmbold P, Brors B et al (2013) Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600). PLoS One 8:e59221","journal-title":"PLoS One"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jaad.2012.03.022","volume":"67","author":"A Skorokhod","year":"2012","unstructured":"Skorokhod A, Capper D, von Deimling A et al (2012) Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1. J Am Acad Dermatol 67:488\u2013491","journal-title":"J Am Acad Dermatol"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1897-4287-10-10","volume":"10","author":"HJ Schulten","year":"2012","unstructured":"Schulten HJ, Salama S, Al-Mansouri Z et al (2012) BRAF mutations in thyroid tumors from an ethnically diverse group. Hered Cancer Clin Pract 10:10","journal-title":"Hered Cancer Clin Pract"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/172460080902400103","volume":"24","author":"I Boulalas","year":"2009","unstructured":"Boulalas I, Zaravinos A, Delakas D et al (2009) Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder. Int J Biol Markers 24:17\u201321","journal-title":"Int J Biol Markers"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/sj.bjc.6606072","volume":"104","author":"J Lin","year":"2011","unstructured":"Lin J, Goto Y, Murata H et al (2011) Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression. Br J Cancer 104:464\u2013468","journal-title":"Br J Cancer"},{"key":"6_CR18","first-page":"6483","volume":"9","author":"K Omholt","year":"2003","unstructured":"Omholt K, Platz A, Kanter L et al (2003) NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res 9:6483\u20136488","journal-title":"Clin Cancer Res"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.humpath.2005.04.011","volume":"36","author":"V Trovisco","year":"2005","unstructured":"Trovisco V, Soares P, Soares R et al (2005) A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Hum Pathol 36:694\u2013697","journal-title":"Hum Pathol"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1053\/j.gastro.2004.08.051","volume":"127","author":"BM Helmke","year":"2004","unstructured":"Helmke BM, Mollenhauer J, Herold-Mende C et al (2004) BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology 127:1815\u20131820","journal-title":"Gastroenterology"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0560.2006.00646.x","volume":"34","author":"JO Indsto","year":"2007","unstructured":"Indsto JO, Kumar S, Wang L et al (2007) Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. J Cutan Pathol 34:448\u2013455","journal-title":"J Cutan Pathol"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4161\/cc.6.3.3818","volume":"6","author":"P Hou","year":"2007","unstructured":"Hou P, Liu D, Xing M (2007) Functional characterization of the T1799-1801del and A1799-1816ins BRAF mutations in papillary thyroid cancer. Cell Cycle 6:377\u2013379","journal-title":"Cell Cycle"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1210\/jc.2007-1179","volume":"92","author":"C Lupi","year":"2007","unstructured":"Lupi C, Giannini R, Ugolini C et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92:4085\u20134090","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2407-5-58","volume":"5","author":"M Deichmann","year":"2005","unstructured":"Deichmann M, Thome M, Benner A et al (2005) Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous\/subcutaneous metastases. BMC Cancer 5:58","journal-title":"BMC Cancer"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/thy.2011.0123","volume":"22","author":"CK Jung","year":"2012","unstructured":"Jung CK, Im SY, Kang YJ et al (2012) Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma. Thyroid 22:791\u2013797","journal-title":"Thyroid"},{"key":"6_CR26","first-page":"139","volume":"29","author":"M Deichmann","year":"2006","unstructured":"Deichmann M, Krahl D, Thome M et al (2006) The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. Int J Oncol 29:139\u2013145","journal-title":"Int J Oncol"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/humu.20955","volume":"30","author":"A Sarkozy","year":"2009","unstructured":"Sarkozy A, Carta C, Moretti S et al (2009) Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 30:695\u2013702","journal-title":"Hum Mutat"},{"key":"6_CR28","first-page":"5761","volume":"63","author":"F Cruz 3rd","year":"2003","unstructured":"Cruz F 3rd, Rubin BP, Wilson D et al (2003) Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res 63:5761\u20135766","journal-title":"Cancer Res"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1158\/1078-0432.CCR-12-1103","volume":"18","author":"SM Hunter","year":"2012","unstructured":"Hunter SM, Gorringe KL, Christie M et al (2012) Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations. Clin Cancer Res 18:5267\u20135277","journal-title":"Clin Cancer Res"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","volume":"7","author":"T Satoh","year":"2012","unstructured":"Satoh T, Smith A, Sarde A et al (2012) B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS One 7:e33891","journal-title":"PLoS One"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/ijc.25893","volume":"129","author":"AE Eisenhardt","year":"2011","unstructured":"Eisenhardt AE, Olbrich H, R\u00f6ring M et al (2011) Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Int J Cancer 129:2297\u20132303","journal-title":"Int J Cancer"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2265.2005.02401.x","volume":"64","author":"C Carta","year":"2006","unstructured":"Carta C, Moretti S, Passeri L et al (2006) Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clin Endocrinol (Oxf) 64:105\u2013109","journal-title":"Clin Endocrinol (Oxf)"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ijc.27709","volume":"132","author":"M Matsuse","year":"2013","unstructured":"Matsuse M, Mitsutake N, Tanimura S et al (2013) Functional characterization of the novel BRAF complex mutation, BRAF(V600delinsYM), identified in papillary thyroid carcinoma. Int J Cancer 132:738\u2013743","journal-title":"Int J Cancer"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/j.0022-202X.2004.22530.x","volume":"122","author":"M Gill","year":"2004","unstructured":"Gill M, Renwick N, Silvers DN et al (2004) Lack of BRAF mutations in Spitz nevi. J Invest Dermatol 122:1325\u20131326","journal-title":"J Invest Dermatol"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12022-009-9073-3","volume":"20","author":"S Chiosea","year":"2009","unstructured":"Chiosea S, Nikiforova M, Zuo H et al (2009) A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol 20:122\u2013126","journal-title":"Endocr Pathol"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1158\/1055-9965.EPI-06-1038","volume":"16","author":"NE Thomas","year":"2007","unstructured":"Thomas NE, Edminston SN, Alexander A et al (2007) Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev 16:991\u2013997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","volume":"121","author":"G Schindler","year":"2011","unstructured":"Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121:397\u2013405","journal-title":"Acta Neuropathol"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/EJE-08-0239","volume":"159","author":"L Barzon","year":"2008","unstructured":"Barzon L, Masi G, Boschin IM et al (2008) Characterization of a novel complex BRAF mutation in a follicular variant papillary thyroid carcinoma. Eur J Endocrinol 159:77\u201380","journal-title":"Eur J Endocrinol"}],"container-title":["Methods in Molecular Biology","Pyrosequencing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-2715-9_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T18:00:58Z","timestamp":1674237658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-2715-9_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9781493927142","9781493927159"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-2715-9_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2015]]}}}